Givaudan SA (OTCMKTS:GVDNY – Get Free Report) shares saw unusually-strong trading volume on Thursday . Approximately 316,396 shares were traded during mid-day trading, an increase of 416% from the previous session’s volume of 61,275 shares.The stock last traded at $68.31 and had previously closed at $68.23.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on GVDNY shares. Berenberg Bank downgraded Givaudan from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Deutsche Bank Aktiengesellschaft reissued a “buy” rating on shares of Givaudan in a research note on Friday, January 30th. Zacks Research lowered Givaudan from a “hold” rating to a “strong sell” rating in a research report on Friday, March 27th. Citigroup reiterated a “neutral” rating on shares of Givaudan in a report on Tuesday, February 3rd. Finally, Barclays downgraded shares of Givaudan from a “strong-buy” rating to a “hold” rating in a research report on Friday, March 27th. Two investment analysts have rated the stock with a Buy rating, three have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, Givaudan has an average rating of “Hold”.
Read Our Latest Report on GVDNY
Givaudan Stock Performance
About Givaudan
Givaudan is a Swiss-based global company that develops, manufactures and supplies flavors, fragrances and active cosmetic ingredients for a broad range of consumer products. The company’s core activities are organized around creating taste and scent solutions—ranging from fine fragrances and consumer-packaged goods scents to flavor systems for food and beverages and functional ingredients for personal care. Givaudan works with brand owners and manufacturers to design sensory experiences, improve product performance and meet formulation or regulatory requirements.
Its product and service offerings include bespoke fragrance creation, flavor formulation, natural ingredient sourcing, aroma chemicals, taste modulators and application support such as prototyping and sensory testing.
Read More
Receive News & Ratings for Givaudan Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Givaudan and related companies with MarketBeat.com's FREE daily email newsletter.
